The assessment and selection of oocytes and embryos is fundamental to the live birth rate data of all IVF units, the parameter that is used to gauge a clinic's success and credibility. This new atlas contains over 1000 high-quality images of oocytes, zygotes and embryos, presented with accompanying data on indications for treatment, stimulation type and duration, as well as short medical histories of each couple and final outcome of treatment. All images in the book can be downloaded from the accompanying CD-ROM. Structured on a patient-by-patient basis, the atlas describes 100 clinically documented case studies that follow the evolution of oocytes and zygotes between day two and day five. Pronuclear morphology and synchrony as well as embryo morphology are reported and described for each case. Written and produced by experienced embryologists, this practical atlas is an important resource for clinical embryologists and physicians in reproductive medicine.
Marc Van den Bergh is Senior Clinical Embryologist and Laboratory Director of the Fertility Laboratory, Kantonsspital Baden, Switzerland. Thomas Ebner is Scientific Lab Director at the Landes- Frauen- und Kinderklinik, Linz, Austria. Kay Elder is Senior Research Scientist, Bourn Hall Clinic, Bourn, Cambridge, UK.
Introduction; Female indications for treatment; Clinical and laboratory protocols; Controlled ovarian hyperstimulation; Sperm preparation; ICSI; In vitro culture system; Oocyte and embryo assessment; Case histories: Part I. 'KSB': Cleavage Stage Transfer (Case Numbers 1-80): 1. No female indication identified (cases 1-33); 2. Tubal infertility (cases 34-40); 3. Cervical hostility/fibroids (cases 41-44); 4. Endometriosis (cases 45-60); 5. Poor responder or ovulatory dysfunction (cases 61-71); 6. Polycystic ovarian disease (cases 72-74); 7. Hyperprolactinaemia/Hypothyroid (cases 75-79); 8. Recurrent abortion (case 80); Part II. 'Linz': Extended Culture to Blastocyst Stage (Case Numbers 81-111): 9. No female indication identified (cases 81-92); 10. Unexplained, failed IVF (cases 93-94); 11. Tubal infertility (cases 95-98); 12. Endometriosis (cases 99-102); 13. Polycystic ovarian disease (cases 103-109); 14. Premature ovarian failure (case 110); 15. Translocation (case 111).